FDA Assigns October 22, 2010, PDUFA Date SAN DIEGO, Feb. 26, 2010 (HSMN NewsFeed) — Arena Pharmaceuticals, Inc. (Nasdaq:ARNA ) announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date o…
Biopharmaceuticals
Arena Pharmaceuticals, lorcaserin, BLOOM, BLOSSOM, Obesity

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Arena Pharmaceuticals Receives PDUFA Date for Lorcaserin NDA”
Leave a Comment